286 related articles for article (PubMed ID: 11997500)
1. Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease.
Zumbansen M; Stoffel W
Mol Cell Biol; 2002 Jun; 22(11):3633-8. PubMed ID: 11997500
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of acid and neutral sphingomyelinases in vitro and in vivo.
Stoffel W
Chem Phys Lipids; 1999 Nov; 102(1-2):107-21. PubMed ID: 11001565
[TBL] [Abstract][Full Text] [Related]
3. Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease).
Otterbach B; Stoffel W
Cell; 1995 Jun; 81(7):1053-61. PubMed ID: 7600574
[TBL] [Abstract][Full Text] [Related]
4. Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease.
Horinouchi K; Erlich S; Perl DP; Ferlinz K; Bisgaier CL; Sandhoff K; Desnick RJ; Stewart CL; Schuchman EH
Nat Genet; 1995 Jul; 10(3):288-93. PubMed ID: 7670466
[TBL] [Abstract][Full Text] [Related]
5. Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling?
Tomiuk S; Hofmann K; Nix M; Zumbansen M; Stoffel W
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3638-43. PubMed ID: 9520418
[TBL] [Abstract][Full Text] [Related]
6. Ceramide as an activator lipid of cathepsin D.
Heinrich M; Wickel M; Winoto-Morbach S; Schneider-Brachert W; Weber T; Brunner J; Saftig P; Peters C; Krönke M; Schütze S
Adv Exp Med Biol; 2000; 477():305-15. PubMed ID: 10849758
[TBL] [Abstract][Full Text] [Related]
7. Subcellular localization of acid sphingomyelinase and lipid in Niemann-Pick mice.
Sakiyama T; Akashi K; Akatsuka A; Owada M; Miyawaki S; Kitagawa T
J Inherit Metab Dis; 1987; 10(3):301-4. PubMed ID: 2828764
[No Abstract] [Full Text] [Related]
8. Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease.
Schuchman EH
FEBS Lett; 2010 May; 584(9):1895-900. PubMed ID: 19944693
[TBL] [Abstract][Full Text] [Related]
9. [Advances in molecular genetics of the Niemann-Pick group of diseases].
Ohno K
Nihon Rinsho; 1993 Sep; 51(9):2293-9. PubMed ID: 8411705
[TBL] [Abstract][Full Text] [Related]
10. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.
Christomanou H
Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1489-502. PubMed ID: 6256275
[TBL] [Abstract][Full Text] [Related]
11. Niemann-Pick Disease versus acid sphingomyelinase deficiency.
Lozano J; Morales A; Cremesti A; Fuks Z; Tilly JL; Schuchman E; Gulbins E; Kolesnick R
Cell Death Differ; 2001 Jan; 8(1):100-3. PubMed ID: 11313707
[No Abstract] [Full Text] [Related]
12. Evidence for the association of ultraviolet-C and H(2)O(2)-induced apoptosis with acid sphingomyelinase activation.
Komatsu M; Takahashi T; Abe T; Takahashi I; Ida H; Takada G
Biochim Biophys Acta; 2001 Aug; 1533(1):47-54. PubMed ID: 11514235
[TBL] [Abstract][Full Text] [Related]
13. Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development.
Stoffel W; Jenke B; Blöck B; Zumbansen M; Koebke J
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4554-9. PubMed ID: 15764706
[TBL] [Abstract][Full Text] [Related]
14. Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene.
Schissel SL; Schuchman EH; Williams KJ; Tabas I
J Biol Chem; 1996 Aug; 271(31):18431-6. PubMed ID: 8702487
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase.
Hofmann K; Tomiuk S; Wolff G; Stoffel W
Proc Natl Acad Sci U S A; 2000 May; 97(11):5895-900. PubMed ID: 10823942
[TBL] [Abstract][Full Text] [Related]
16. The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.
Smith EL; Schuchman EH
FASEB J; 2008 Oct; 22(10):3419-31. PubMed ID: 18567738
[TBL] [Abstract][Full Text] [Related]
17. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease.
He X; Chen F; Gatt S; Schuchman EH
Anal Biochem; 2001 Jun; 293(2):204-11. PubMed ID: 11399033
[TBL] [Abstract][Full Text] [Related]
18. Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease.
Ikegami M; Dhami R; Schuchman EH
Am J Physiol Lung Cell Mol Physiol; 2003 Mar; 284(3):L518-25. PubMed ID: 12495943
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells from acid sphingomyelinase-deficient mice: implications for Niemann-Pick disease gene therapy and the development of improved stem cell gene transfer procedures.
Erlich S; Miranda SR; Visser JW; Dagan A; Gatt S; Schuchman EH
Blood; 1999 Jan; 93(1):80-6. PubMed ID: 9864149
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid.
Opreanu M; Lydic TA; Reid GE; McSorley KM; Esselman WJ; Busik JV
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3253-63. PubMed ID: 20071681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
